Antithrombotic agents in coronary artery disease.
Cairns
J A
JA
Faculty of Medicine, University of British Columbia, Vancouver, Canada.
Théroux
P
P
Lewis
H D
HD
Ezekowitz
M
M
Meade
T W
TW
D001241:Aspirin / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000188:drug therapy*; D004617:Embolism / Q000517:prevention & control; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D020521:Stroke / Q000517:prevention & control; D013997:Time Factors; D020246:Venous Thrombosis / Q000517:prevention & control
D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors; D001241:Aspirin